[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

EMEA (Europe, Middle East and Africa) Recombinant Antihemophilic Factor Market Report 2018

April 2018 | 102 pages | ID: E323EC98376EN
QYResearch

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the EMEA Recombinant Antihemophilic Factor market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Recombinant Antihemophilic Factor for these regions, from 2013 to 2025 (forecast)
  • Europe: Germany, France, UK, Russia, Italy and Benelux;
  • Middle East: Saudi Arabia, Israel, UAE and Iran;
  • Africa: South Africa, Nigeria, Egypt and Algeria.
EMEA Recombinant Antihemophilic Factor market competition by top manufacturers/players, with Recombinant Antihemophilic Factor sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Shire (Baxter)
  • Bayer
  • CSL
  • Pfizer
  • Biogen
  • Octapharma
  • NovoNordisk
On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
  • 200IU
  • 250IU
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
  • Hospital
  • Pharmacy
If you have any special requirements, please let us know and we will offer you the report as you want.
EMEA (Europe, Middle East and Africa) Recombinant Antihemophilic Factor Market Report 2018

1 RECOMBINANT ANTIHEMOPHILIC FACTOR OVERVIEW

1.1 Product Overview and Scope of Recombinant Antihemophilic Factor
1.2 Classification of Recombinant Antihemophilic Factor
  1.2.1 EMEA Recombinant Antihemophilic Factor Market Size (Sales) Comparison by Type (2013-2025)
  1.2.2 EMEA Recombinant Antihemophilic Factor Market Size (Sales) Market Share by Type (Product Category) in 2017
  1.2.3 200IU
  1.2.4 250IU
1.3 EMEA Recombinant Antihemophilic Factor Market by Application/End Users
  1.3.1 EMEA Recombinant Antihemophilic Factor Sales (Volume) and Market Share Comparison by Application (2013-2025)
  1.3.2 Hospital
  1.3.3 Pharmacy
1.4 EMEA Recombinant Antihemophilic Factor Market by Region
  1.4.1 EMEA Recombinant Antihemophilic Factor Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 Europe Status and Prospect (2013-2025)
  1.4.3 Middle East Status and Prospect (2013-2025)
  1.4.4 Africa Status and Prospect (2013-2025)
1.5 EMEA Market Size (Value and Volume) of Recombinant Antihemophilic Factor (2013-2025)
  1.5.1 EMEA Recombinant Antihemophilic Factor Sales and Growth Rate (2013-2025)
  1.5.2 EMEA Recombinant Antihemophilic Factor Revenue and Growth Rate (2013-2025)

2 EMEA RECOMBINANT ANTIHEMOPHILIC FACTOR COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Recombinant Antihemophilic Factor Market Competition by Players/Manufacturers
  2.1.1 EMEA Recombinant Antihemophilic Factor Sales Volume and Market Share of Major Players (2013-2018)
  2.1.2 EMEA Recombinant Antihemophilic Factor Revenue and Share by Players (2013-2018)
  2.1.3 EMEA Recombinant Antihemophilic Factor Sale Price by Players (2013-2018)
2.2 EMEA Recombinant Antihemophilic Factor (Volume and Value) by Type/Product Category
  2.2.1 EMEA Recombinant Antihemophilic Factor Sales and Market Share by Type (2013-2018)
  2.2.2 EMEA Recombinant Antihemophilic Factor Revenue and Market Share by Type (2013-2018)
  2.2.3 EMEA Recombinant Antihemophilic Factor Sale Price by Type (2013-2018)
2.3 EMEA Recombinant Antihemophilic Factor (Volume) by Application
2.4 EMEA Recombinant Antihemophilic Factor (Volume and Value) by Region
  2.4.1 EMEA Recombinant Antihemophilic Factor Sales and Market Share by Region (2013-2018)
  2.4.2 EMEA Recombinant Antihemophilic Factor Revenue and Market Share by Region (2013-2018)
  2.4.3 EMEA Recombinant Antihemophilic Factor Sales Price by Region (2013-2018)

3 EUROPE RECOMBINANT ANTIHEMOPHILIC FACTOR (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Recombinant Antihemophilic Factor Sales and Value (2013-2018)
  3.1.1 Europe Recombinant Antihemophilic Factor Sales Volume and Growth Rate (2013-2018)
  3.1.2 Europe Recombinant Antihemophilic Factor Revenue and Growth Rate (2013-2018)
3.2 Europe Recombinant Antihemophilic Factor Sales and Market Share by Type
3.3 Europe Recombinant Antihemophilic Factor Sales and Market Share by Application
3.4 Europe Recombinant Antihemophilic Factor Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Recombinant Antihemophilic Factor Sales Volume by Countries (2013-2018)
  3.4.2 Europe Recombinant Antihemophilic Factor Revenue by Countries (2013-2018)
  3.4.3 Germany Recombinant Antihemophilic Factor Sales and Growth Rate (2013-2018)
  3.4.4 France Recombinant Antihemophilic Factor Sales and Growth Rate (2013-2018)
  3.4.5 UK Recombinant Antihemophilic Factor Sales and Growth Rate (2013-2018)
  3.4.6 Russia Recombinant Antihemophilic Factor Sales and Growth Rate (2013-2018)
  3.4.7 Italy Recombinant Antihemophilic Factor Sales and Growth Rate (2013-2018)
  3.4.8 Benelux Recombinant Antihemophilic Factor Sales and Growth Rate (2013-2018)

4 MIDDLE EAST RECOMBINANT ANTIHEMOPHILIC FACTOR (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Recombinant Antihemophilic Factor Sales and Value (2013-2018)
  4.1.1 Middle East Recombinant Antihemophilic Factor Sales Volume and Growth Rate (2013-2018)
  4.1.2 Middle East Recombinant Antihemophilic Factor Revenue and Growth Rate (2013-2018)
4.2 Middle East Recombinant Antihemophilic Factor Sales and Market Share by Type
4.3 Middle East Recombinant Antihemophilic Factor Sales and Market Share by Application
4.4 Middle East Recombinant Antihemophilic Factor Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Recombinant Antihemophilic Factor Sales Volume by Countries (2013-2018)
  4.4.2 Middle East Recombinant Antihemophilic Factor Revenue by Countries (2013-2018)
  4.4.3 Saudi Arabia Recombinant Antihemophilic Factor Sales and Growth Rate (2013-2018)
  4.4.4 Israel Recombinant Antihemophilic Factor Sales and Growth Rate (2013-2018)
  4.4.5 UAE Recombinant Antihemophilic Factor Sales and Growth Rate (2013-2018)
  4.4.6 Iran Recombinant Antihemophilic Factor Sales and Growth Rate (2013-2018)

5 AFRICA RECOMBINANT ANTIHEMOPHILIC FACTOR (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Recombinant Antihemophilic Factor Sales and Value (2013-2018)
  5.1.1 Africa Recombinant Antihemophilic Factor Sales Volume and Growth Rate (2013-2018)
  5.1.2 Africa Recombinant Antihemophilic Factor Revenue and Growth Rate (2013-2018)
5.2 Africa Recombinant Antihemophilic Factor Sales and Market Share by Type
5.3 Africa Recombinant Antihemophilic Factor Sales and Market Share by Application
5.4 Africa Recombinant Antihemophilic Factor Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Recombinant Antihemophilic Factor Sales Volume by Countries (2013-2018)
  5.4.2 Africa Recombinant Antihemophilic Factor Revenue by Countries (2013-2018)
  5.4.3 South Africa Recombinant Antihemophilic Factor Sales and Growth Rate (2013-2018)
  5.4.4 Nigeria Recombinant Antihemophilic Factor Sales and Growth Rate (2013-2018)
  5.4.5 Egypt Recombinant Antihemophilic Factor Sales and Growth Rate (2013-2018)
  5.4.6 Algeria Recombinant Antihemophilic Factor Sales and Growth Rate (2013-2018)

6 EMEA RECOMBINANT ANTIHEMOPHILIC FACTOR MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Shire (Baxter)
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Recombinant Antihemophilic Factor Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Shire (Baxter) Recombinant Antihemophilic Factor Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 Bayer
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Recombinant Antihemophilic Factor Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Bayer Recombinant Antihemophilic Factor Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 CSL
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Recombinant Antihemophilic Factor Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 CSL Recombinant Antihemophilic Factor Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview
6.4 Pfizer
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Recombinant Antihemophilic Factor Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Pfizer Recombinant Antihemophilic Factor Sales, Revenue, Price and Gross Margin (2013-2018)
  6.4.4 Main Business/Business Overview
6.5 Biogen
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Recombinant Antihemophilic Factor Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Biogen Recombinant Antihemophilic Factor Sales, Revenue, Price and Gross Margin (2013-2018)
  6.5.4 Main Business/Business Overview
6.6 Octapharma
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Recombinant Antihemophilic Factor Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Octapharma Recombinant Antihemophilic Factor Sales, Revenue, Price and Gross Margin (2013-2018)
  6.6.4 Main Business/Business Overview
6.7 NovoNordisk
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Recombinant Antihemophilic Factor Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 NovoNordisk Recombinant Antihemophilic Factor Sales, Revenue, Price and Gross Margin (2013-2018)
  6.7.4 Main Business/Business Overview

7 RECOMBINANT ANTIHEMOPHILIC FACTOR MANUFACTURING COST ANALYSIS

7.1 Recombinant Antihemophilic Factor Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Recombinant Antihemophilic Factor

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Recombinant Antihemophilic Factor Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Recombinant Antihemophilic Factor Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA RECOMBINANT ANTIHEMOPHILIC FACTOR MARKET FORECAST (2018-2025)

11.1 EMEA Recombinant Antihemophilic Factor Sales, Revenue and Price Forecast (2018-2025)
  11.1.1 EMEA Recombinant Antihemophilic Factor Sales and Growth Rate Forecast (2018-2025)
  11.1.2 EMEA Recombinant Antihemophilic Factor Revenue and Growth Rate Forecast (2018-2025)
  11.1.3 EMEA Recombinant Antihemophilic Factor Price and Trend Forecast (2018-2025)
11.2 EMEA Recombinant Antihemophilic Factor Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.3 Europe Recombinant Antihemophilic Factor Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.4 Middle Eastt Recombinant Antihemophilic Factor Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.5 Africa Recombinant Antihemophilic Factor Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.6 EMEA Recombinant Antihemophilic Factor Sales Forecast by Type (2018-2025)
11.7 EMEA Recombinant Antihemophilic Factor Sales Forecast by Application (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of Recombinant Antihemophilic Factor
Figure EMEA Recombinant Antihemophilic Factor Sales Volume (K Units) by Type (2013-2025)
Figure EMEA Recombinant Antihemophilic Factor Sales Volume Market Share by Type (Product Category) in 2017
Figure 200IU Product Picture
Figure 250IU Product Picture
Figure EMEA Recombinant Antihemophilic Factor Sales Volume (K Units) by Application (2013-2025)
Figure EMEA Sales Market Share of Recombinant Antihemophilic Factor by Application in 2017
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Pharmacy Examples
Table Key Downstream Customer in Pharmacy
Figure EMEA Recombinant Antihemophilic Factor Market Size (Million USD) by Region (2013-2025)
Figure Europe Recombinant Antihemophilic Factor Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Recombinant Antihemophilic Factor Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Recombinant Antihemophilic Factor Revenue (Million USD) and Growth Rate (2013-2025)
Figure Middle East Recombinant Antihemophilic Factor Revenue (Million USD) Status and Forecast by Countries
Figure Africa Recombinant Antihemophilic Factor Revenue (Million USD) and Growth Rate (2013-2025)
Figure Africa Recombinant Antihemophilic Factor Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Recombinant Antihemophilic Factor Sales Volume and Growth Rate (2013-2025)
Figure EMEA Recombinant Antihemophilic Factor Revenue (Million USD) and Growth Rate (2013-2025)
Figure EMEA Recombinant Antihemophilic Factor Market Major Players Product Sales Volume (K Units) (2013-2018)
Table EMEA Recombinant Antihemophilic Factor Sales Volume (K Units) of Major Players (2013-2018)
Table EMEA Recombinant Antihemophilic Factor Sales Share by Players (2013-2018)
Figure 2017 Recombinant Antihemophilic Factor Sales Share by Players
Figure 2017 Recombinant Antihemophilic Factor Sales Share by Players
Figure EMEA Recombinant Antihemophilic Factor Market Major Players Product Revenue (Million USD) (2013-2018)
Table EMEA Recombinant Antihemophilic Factor Revenue (Million USD) by Players (2013-2018)
Table EMEA Recombinant Antihemophilic Factor Revenue Share by Players (2013-2018)
Table 2017 EMEA Recombinant Antihemophilic Factor Revenue Share by Players
Table 2017 EMEA Recombinant Antihemophilic Factor Revenue Share by Players
Table EMEA Recombinant Antihemophilic Factor Sale Price (USD/Unit) by Players (2013-2018)
Table EMEA Recombinant Antihemophilic Factor Sales (K Units) and Market Share by Type (2013-2018)
Table EMEA Recombinant Antihemophilic Factor Sales Share by Type (2013-2018)
Figure Sales Market Share of Recombinant Antihemophilic Factor by Type (2013-2018)
Figure EMEA Recombinant Antihemophilic Factor Sales Market Share by Type (2013-2018)
Table EMEA Recombinant Antihemophilic Factor Revenue (Million USD) and Market Share by Type (2013-2018)
Table EMEA Recombinant Antihemophilic Factor Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Recombinant Antihemophilic Factor by Type in 2017
Table EMEA Recombinant Antihemophilic Factor Sale Price (USD/Unit) by Type (2013-2018)
Table EMEA Recombinant Antihemophilic Factor Sales (K Units) and Market Share by Application (2013-2018)
Table EMEA Recombinant Antihemophilic Factor Sales Share by Application (2013-2018)
Figure Sales Market Share of Recombinant Antihemophilic Factor by Application (2013-2018)
Figure EMEA Recombinant Antihemophilic Factor Sales Market Share by Application in 2017
Table EMEA Recombinant Antihemophilic Factor Sales (K Units) and Market Share by Region (2013-2018)
Table EMEA Recombinant Antihemophilic Factor Sales Share by Region (2013-2018)
Figure Sales Market Share of Recombinant Antihemophilic Factor by Region (2013-2018)
Figure EMEA Recombinant Antihemophilic Factor Sales Market Share in 2017
Table EMEA Recombinant Antihemophilic Factor Revenue (Million USD) and Market Share by Region (2013-2018)
Table EMEA Recombinant Antihemophilic Factor Revenue Share by Region (2013-2018)
Figure Revenue Market Share of Recombinant Antihemophilic Factor by Region (2013-2018)
Figure EMEA Recombinant Antihemophilic Factor Revenue Market Share Regions in 2017
Table EMEA Recombinant Antihemophilic Factor Sales Price (USD/Unit) by Region (2013-2018)
Figure Europe Recombinant Antihemophilic Factor Sales (K Units) and Growth Rate (2013-2018)
Figure Europe Recombinant Antihemophilic Factor Revenue and Growth Rate (2013-2018)
Table Europe Recombinant Antihemophilic Factor Sales (K Units) by Type (2013-2018)
Table Europe Recombinant Antihemophilic Factor Market Share by Type (2013-2018)
Figure Europe Recombinant Antihemophilic Factor Market Share by Type in 2017
Table Europe Recombinant Antihemophilic Factor Sales (K Units) by Application (2013-2018)
Table Europe Recombinant Antihemophilic Factor Market Share by Application (2013-2018)
Figure Europe Recombinant Antihemophilic Factor Market Share by Application in 2017
Table Europe Recombinant Antihemophilic Factor Sales (K Units) by Countries (2013-2018)
Table Europe Recombinant Antihemophilic Factor Sales Market Share by Countries (2013-2018)
Figure Europe Recombinant Antihemophilic Factor Sales Market Share by Countries (2013-2018)
Figure Europe Recombinant Antihemophilic Factor Sales Market Share by Countries in 2017
Table Europe Recombinant Antihemophilic Factor Revenue (Million USD) by Countries (2013-2018)
Table Europe Recombinant Antihemophilic Factor Revenue Market Share by Countries (2013-2018)
Figure Europe Recombinant Antihemophilic Factor Revenue Market Share by Countries (2013-2018)
Figure Europe Recombinant Antihemophilic Factor Revenue Market Share by Countries in 2017
Figure Germany Recombinant Antihemophilic Factor Sales (K Units) and Growth Rate (2013-2018)
Figure France Recombinant Antihemophilic Factor Sales (K Units) and Growth Rate (2013-2018)
Figure UK Recombinant Antihemophilic Factor Sales (K Units) and Growth Rate (2013-2018)
Figure Russia Recombinant Antihemophilic Factor Sales (K Units) and Growth Rate (2013-2018)
Figure Italy Recombinant Antihemophilic Factor Sales (K Units) and Growth Rate (2013-2018)
Figure Benelux Recombinant Antihemophilic Factor Sales (K Units) and Growth Rate (2013-2018)
Figure Middle East Recombinant Antihemophilic Factor Sales (K Units) and Growth Rate (2013-2018)
Figure Middle East Recombinant Antihemophilic Factor Revenue (Million USD) and Growth Rate (2013-2018)
Table Middle East Recombinant Antihemophilic Factor Sales (K Units) by Type (2013-2018)
Table Middle East Recombinant Antihemophilic Factor Market Share by Type (2013-2018)
Figure Middle East Recombinant Antihemophilic Factor Market Share by Type (2013-2018)
Table Middle East Recombinant Antihemophilic Factor Sales (K Units) by Applications (2013-2018)
Table Middle East Recombinant Antihemophilic Factor Market Share by Applications (2013-2018)
Figure Middle East Recombinant Antihemophilic Factor Sales Market Share by Application in 2017
Table Middle East Recombinant Antihemophilic Factor Sales Volume (K Units) by Countries (2013-2018)
Table Middle East Recombinant Antihemophilic Factor Sales Volume Market Share by Countries (2013-2018)
Figure Middle East Recombinant Antihemophilic Factor Sales Volume Market Share by Countries in 2017
Table Middle East Recombinant Antihemophilic Factor Revenue (Million USD) by Countries (2013-2018)
Table Middle East Recombinant Antihemophilic Factor Revenue Market Share by Countries (2013-2018)
Figure Middle East Recombinant Antihemophilic Factor Revenue Market Share by Countries (2013-2018)
Figure Middle East Recombinant Antihemophilic Factor Revenue Market Share by Countries in 2017
Figure Saudi Arabia Recombinant Antihemophilic Factor Sales (K Units) and Growth Rate (2013-2018)
Figure Israel Recombinant Antihemophilic Factor Sales (K Units) and Growth Rate (2013-2018)
Figure UAE Recombinant Antihemophilic Factor Sales (K Units) and Growth Rate (2013-2018)
Figure Iran Recombinant Antihemophilic Factor Sales (K Units) and Growth Rate (2013-2018)
Figure Africa Recombinant Antihemophilic Factor Sales (K Units) and Growth Rate (2013-2018)
Figure Africa Recombinant Antihemophilic Factor Revenue (Million USD) and Growth Rate (2013-2018)
Table Africa Recombinant Antihemophilic Factor Sales (K Units) by Type (2013-2018)
Table Africa Recombinant Antihemophilic Factor Sales Market Share by Type (2013-2018)
Figure Africa Recombinant Antihemophilic Factor Sales Market Share by Type (2013-2018)
Figure Africa Recombinant Antihemophilic Factor Sales Market Share by Type in 2017
Table Africa Recombinant Antihemophilic Factor Sales (K Units) by Application (2013-2018)
Table Africa Recombinant Antihemophilic Factor Sales Market Share by Application (2013-2018)
Figure Africa Recombinant Antihemophilic Factor Sales Market Share by Application (2013-2018)
Table Africa Recombinant Antihemophilic Factor Sales Volume (K Units) by Countries (2013-2018)
Table Africa Recombinant Antihemophilic Factor Sales Market Share by Countries (2013-2018)
Figure Africa Recombinant Antihemophilic Factor Sales Market Share by Countries (2013-2018)
Figure Africa Recombinant Antihemophilic Factor Sales Market Share by Countries in 2017
Table Africa Recombinant Antihemophilic Factor Revenue (Million USD) by Countries (2013-2018)
Table Africa Recombinant Antihemophilic Factor Revenue Market Share by Countries (2013-2018)
Figure Africa Recombinant Antihemophilic Factor Revenue Market Share by Countries (2013-2018)
Figure Africa Recombinant Antihemophilic Factor Revenue Market Share by Countries in 2017
Figure South Africa Recombinant Antihemophilic Factor Sales (K Units) and Growth Rate (2013-2018)
Figure Nigeria Recombinant Antihemophilic Factor Sales (K Units) and Growth Rate (2013-2018)
Figure Egypt Recombinant Antihemophilic Factor Sales (K Units) and Growth Rate (2013-2018)
Figure Algeria Recombinant Antihemophilic Factor Sales (K Units) and Growth Rate (2013-2018)
Table Shire (Baxter) Recombinant Antihemophilic Factor Basic Information List
Table Shire (Baxter) Recombinant Antihemophilic Factor Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Shire (Baxter) Recombinant Antihemophilic Factor Sales (K Units) and Growth Rate (2013-2018)
Figure Shire (Baxter) Recombinant Antihemophilic Factor Sales Market Share in EMEA (2013-2018)
Figure Shire (Baxter) Recombinant Antihemophilic Factor Revenue Market Share in EMEA (2013-2018)
Table Bayer Recombinant Antihemophilic Factor Basic Information List
Table Bayer Recombinant Antihemophilic Factor Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Bayer Recombinant Antihemophilic Factor Sales (K Units) and Growth Rate (2013-2018)
Figure Bayer Recombinant Antihemophilic Factor Sales Market Share in EMEA (2013-2018)
Figure Bayer Recombinant Antihemophilic Factor Revenue Market Share in EMEA (2013-2018)
Table CSL Recombinant Antihemophilic Factor Basic Information List
Table CSL Recombinant Antihemophilic Factor Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure CSL Recombinant Antihemophilic Factor Sales (K Units) and Growth Rate (2013-2018)
Figure CSL Recombinant Antihemophilic Factor Sales Market Share in EMEA (2013-2018)
Figure CSL Recombinant Antihemophilic Factor Revenue Market Share in EMEA (2013-2018)
Table Pfizer Recombinant Antihemophilic Factor Basic Information List
Table Pfizer Recombinant Antihemophilic Factor Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Pfizer Recombinant Antihemophilic Factor Sales (K Units) and Growth Rate (2013-2018)
Figure Pfizer Recombinant Antihemophilic Factor Sales Market Share in EMEA (2013-2018)
Figure Pfizer Recombinant Antihemophilic Factor Revenue Market Share in EMEA (2013-2018)
Table Biogen Recombinant Antihemophilic Factor Basic Information List
Table Biogen Recombinant Antihemophilic Factor Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Biogen Recombinant Antihemophilic Factor Sales (K Units) and Growth Rate (2013-2018)
Figure Biogen Recombinant Antihemophilic Factor Sales Market Share in EMEA (2013-2018)
Figure Biogen Recombinant Antihemophilic Factor Revenue Market Share in EMEA (2013-2018)
Table Octapharma Recombinant Antihemophilic Factor Basic Information List
Table Octapharma Recombinant Antihemophilic Factor Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Octapharma Recombinant Antihemophilic Factor Sales (K Units) and Growth Rate (2013-2018)
Figure Octapharma Recombinant Antihemophilic Factor Sales Market Share in EMEA (2013-2018)
Figure Octapharma Recombinant Antihemophilic Factor Revenue Market Share in EMEA (2013-2018)
Table NovoNordisk Recombinant Antihemophilic Factor Basic Information List
Table NovoNordisk Recombinant Antihemophilic Factor Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure NovoNordisk Recombinant Antihemophilic Factor Sales (K Units) and Growth Rate (2013-2018)
Figure NovoNordisk Recombinant Antihemophilic Factor Sales Market Share in EMEA (2013-2018)
Figure NovoNordisk Recombinant Antihemophilic Factor Revenue Market Share in EMEA (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Recombinant Antihemophilic Factor
Figure Manufacturing Process Analysis of Recombinant Antihemophilic Factor
Figure Recombinant Antihemophilic Factor Industrial Chain Analysis
Table Raw Materials Sources of Recombinant Antihemophilic Factor Major Manufacturers in 2017
Table Major Buyers of Recombinant Antihemophilic Factor
Table Distributors/Traders List
Figure EMEA Recombinant Antihemophilic Factor Sales (K Units) and Growth Rate Forecast (2018-2025)
Figure EMEA Recombinant Antihemophilic Factor Revenue and Growth Rate Forecast (2018-2025)
Figure EMEA Recombinant Antihemophilic Factor Price (USD/Unit) and Trend Forecast (2018-2025)
Table EMEA Recombinant Antihemophilic Factor Sales (K Units) Forecast by Region (2018-2025)
Figure EMEA Recombinant Antihemophilic Factor Sales Market Share Forecast by Region (2018-2025)
Table EMEA Recombinant Antihemophilic Factor Revenue (Million USD) Forecast by Region (2018-2025)
Figure EMEA Recombinant Antihemophilic Factor Revenue Market Share Forecast by Region (2018-2025)
Table Europe Recombinant Antihemophilic Factor Sales (K Units) Forecast by Countries (2018-2025)
Figure Europe Recombinant Antihemophilic Factor Sales Market Share Forecast by Countries (2018-2025)
Table Europe Recombinant Antihemophilic Factor Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Europe Recombinant Antihemophilic Factor Revenue Market Share Forecast by Countries (2018-2025)
Table Middle East Recombinant Antihemophilic Factor Sales (K Units) Forecast by Countries (2018-2025)
Figure Middle East Recombinant Antihemophilic Factor Sales Market Share Forecast by Countries (2018-2025)
Table Middle East Recombinant Antihemophilic Factor Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Middle East Recombinant Antihemophilic Factor Revenue Market Share Forecast by Countries (2018-2025)
Table Africa Recombinant Antihemophilic Factor Sales (K Units) Forecast by Countries (2018-2025)
Figure Africa Recombinant Antihemophilic Factor Sales Market Share Forecast by Countries (2018-2025)
Table Africa Recombinant Antihemophilic Factor Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Africa Recombinant Antihemophilic Factor Revenue Market Share Forecast by Countries (2018-2025)
Table EMEA Recombinant Antihemophilic Factor Sales (K Units) Forecast by Type (2018-2025)
Figure EMEA Recombinant Antihemophilic Factor Sales Market Share Forecast by Type (2018-2025)
Table EMEA Recombinant Antihemophilic Factor Sales (K Units) Forecast by Application (2018-2025)
Figure EMEA Recombinant Antihemophilic Factor Sales Market Share Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories